Form 4: Cryoport Director Sells 2,500 Shares in Open Market Transaction

Cryoport director Robert J. Hariri sold 2,500 shares of common stock at an average price of $6.48 on November 21, 2024.

Summary

• Robert J. Hariri, a director at Cryoport, Inc., sold 2,500 shares of the company's common stock on November 21, 2024.
• The shares were sold at a weighted average price of $6.48 per share.
• The sale was executed in multiple transactions with prices ranging from $6.40 to $6.60 per share.
• Following the transaction, Mr. Hariri directly owns 20,561 shares of Cryoport common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a director, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity. It is common for directors and officers to buy and sell shares of their company's stock. The sale does not appear to be significant in size.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US.
• The sale of 2,500 shares by a director is not unusual and is relatively small compared to the total outstanding shares of Cryoport.
• Similar filings are made by directors and officers of companies like Thermo Fisher Scientific (TMO) and Danaher Corporation (DHR) when they trade their company's stock.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect on the company's operations or financial position.

Key Dates

Keywords

Cryoport, CYRX, Robert J. Hariri, stock sale, insider trading, director, common stock